PAMU
EBS icon

Pictet Asset Management (UK)’s Emergent Biosolutions EBS Stock Holding History

Pictet Asset Management (UK)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3.29M Sell
52,249
-14,454
-22% -$929K ﹤0.01% 929
2021
Q1 		$6.2M Buy
66,703
+20,041
+43% +$2.05M 0.01% 783
2020
Q4 		$4.18M Buy
46,662
+15,685
+51% +$1.44M 0.01% 850
2020
Q3 		$3.2M Buy
+30,977
New +$3.34M 0.01% 818

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management (UK)'s EBS Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Emergent Biosolutions (EBS) stake by 22% in Q2 2021, selling an estimated $929K and leaving 52,249 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #929.

Pictet Asset Management (UK) first reported a position in EBS in Q3 2020 and has held it in 4 quarters since. The position peaked at $6.2M in Q1 2021. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Pictet Asset Management (UK) held 52,249 shares of Emergent Biosolutions worth $3.29M as of Q2 2021.
  • Pictet Asset Management (UK) sold 14,454 Emergent Biosolutions shares in Q2 2021, an estimated $929K.
  • Emergent Biosolutions made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #929 holding.
  • Pictet Asset Management (UK) first reported a position in Emergent Biosolutions in Q3 2020 and has held it in 4 quarters since.
  • Pictet Asset Management (UK)'s Emergent Biosolutions position peaked at $6.2M in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.